Ajanta Pharma
₹2,149.7
+9.75 (0.46%)
- Advice
- Hold
26 April, 2024 10:05 BSE: 532331
NSE: AJANTPHARMISIN: INE031B01049
Start SIP in Ajanta Pharma
Start SIPAjanta Pharma Performance
Day Range
- Low 2,141
- High 2,157
52 Week Range
- Low 1,247
- High 2,354
- Open Price2,144
- Previous Close2,140
- Volume3570
Ajanta Pharma Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 1,085 | 945 | 1,015 | 849 |
Operating Expenses Qtr Cr | 758 | 672 | 738 | 704 |
Operating Profit Qtr Cr | 327 | 274 | 277 | 145 |
Depreciation Qtr Cr | 33 | 33 | 32 | 32 |
Interest Qtr Cr | 2 | 2 | 1 | 1 |
Tax Qtr Cr | 85 | 78 | 63 | 31 |
Net Profit Qtr Cr | 220 | 212 | 212 | 117 |
Ajanta Pharma Technicals
EMA & SMA
Current Price
₹2,149.7
+9.75 (0.46%)
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹2,132.84
- 50 Day
- ₹2,132.68
- 100 Day
- ₹2,077.85
- 200 Day
- ₹1,927.00
- 20 Day
- ₹2,157.32
- 50 Day
- ₹2,136.92
- 100 Day
- ₹2,114.35
- 200 Day
- ₹1,918.33
Ajanta Pharma Resistance and Support
PIVOT
₹2,136.45
Resistance | |
---|---|
First Resistance | 2,147.85 |
Second Resistance | 2,155.75 |
Third Resistance | 2,167.15 |
RSI | 50.69 |
MFI | 42.99 |
MACD Single Line | -7.48 |
MACD | -9.78 |
Support | |
---|---|
First Resistance | 2,128.55 |
Second Resistance | 2,117.15 |
Third Resistance | 2,109.25 |
Ajanta Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 35,868 | 2,834,648 | 79.03 |
Week | 76,750 | 5,753,210 | 74.96 |
1 Month | 101,780 | 6,527,131 | 64.13 |
6 Month | 141,402 | 8,393,605 | 59.36 |
Ajanta Pharma Result Highlights
Ajanta Pharma Synopsis
NSE-Medical-Generic Drugs
Ajanta Pharma Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3411.27 Cr. and Equity Capital is Rs. 25.27 Cr. for the Year ended 31/03/2023. Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059.Market Cap | 27,072 |
Sales | 3,894 |
Shares in Float | 4.28 |
No of funds | 263 |
Yield | 1.68 |
Book Value | 8.33 |
U/D Vol ratio | 1.3 |
LTDebt / Equity | |
Alpha | 0.16 |
Beta | 0.46 |
Ajanta Pharma
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 66.21% | 66.21% | 66.21% | 66.21% |
Mutual Funds | 14.76% | 13.86% | 12.84% | 13.07% |
Insurance Companies | 2.16% | 2.15% | 2.07% | 1.64% |
Foreign Portfolio Investors | 8.54% | 9.11% | 9.99% | 10.19% |
Financial Institutions/ Banks | ||||
Individual Investors | 6.91% | 7.07% | 7.21% | 6.92% |
Others | 1.42% | 1.6% | 1.68% | 1.97% |
Ajanta Pharma Management
Name | Designation |
---|---|
Mr. Mannalal B Agrawal | Chairman |
Mr. Madhusudan B Agrawal | Vice Chairman |
Mr. Yogesh M Agrawal | Managing Director |
Mr. Rajesh M Agrawal | Joint Managing Director |
Mr. Chandrakant M Khetan | Independent Director |
Mr. K H Viswanathan | Independent Director |
Mr. Prabhakar R Dalal | Independent Director |
Dr. Anjana Grewal | Independent Director |
Ajanta Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Ajanta Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-02 | Audited Results | |
2024-01-31 | Quarterly Results & 2nd Interim Dividend | |
2023-10-31 | Quarterly Results | |
2023-07-27 | Quarterly Results | |
2023-05-05 | Audited Results |
Date | Purpose | Remarks |
---|---|---|
2024-02-08 | INTERIM | Rs.26.00 per share(1300%)Second Interim Dividend |
2023-08-04 | SPECIAL | Rs.15.00 per share(750%)Special Dividend |
2023-08-04 | INTERIM | Rs.10.00 per share(500%)First Interim Dividend |
2022-11-14 | INTERIM | Rs.7.00 per share(350%)Interim Dividend |
2021-11-10 | INTERIM | Rs.9.50 per share(475%)Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2022-06-23 | Bonus | Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-. |
Ajanta Pharma FAQs
What is Share Price of Ajanta Pharma ?
Ajanta Pharma share price is ₹2,149 As on 26 April, 2024 | 09:51
What is the Market Cap of Ajanta Pharma ?
The Market Cap of Ajanta Pharma is ₹27068.1 Cr As on 26 April, 2024 | 09:51
What is the P/E ratio of Ajanta Pharma ?
The P/E ratio of Ajanta Pharma is 36.8 As on 26 April, 2024 | 09:51
What is the PB ratio of Ajanta Pharma ?
The PB ratio of Ajanta Pharma is 8 As on 26 April, 2024 | 09:51